Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00622037 · ClinicalTrials.gov registry record · Phase 4
Bilateral, Masked Comparison of PEG-400 Based Artificial Tear and Systane for the Treatment of Dry Eye Signs, Symptoms and Visual Quality
A Phase 4 study, sponsored by Bp Consulting.
- Completed
- Registry status
- Phase 4
- Development phase
- 70
- Enrollment target
NCT00622037 is a Phase 4 study that has completed, run by Bp Consulting. The registered enrollment target is 70 participants.
The verdict
NCT00622037, a Phase 4 study, has completed, sponsored by Bp Consulting.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 70 participants
- Enrollment target
Study Summary
To evaluate and compare the effects of PEG-400 based artificial tear and Systane tears in mild-moderate dry eye patients. TBUT, Visual impact and subjective evaluations will be assessed in this month long trial.
Interventions
- DRUG Systane
- DRUG PEG-400 based artificial tear
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2008-02 |
| Est. Completion | 2008-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00622037
The ClinicalTrials.gov registry entry for NCT00622037 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bp Consulting, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Systane is the first listed.
NCT00622037 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00622037 about?
NCT00622037 is a clinical study titled "Bilateral, Masked Comparison of PEG-400 Based Artificial Tear and Systane for the Treatment of Dry Eye Signs, Symptoms and Visual Quality". To evaluate and compare the effects of PEG-400 based artificial tear and Systane tears in mild-moderate dry eye patients. TBUT, Visual impact and subjective evaluations will be assessed in this month long trial.
What is the current status of trial NCT00622037?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 70 participants. The study started on 2008-02. Estimated completion is 2008-05.
What interventions are being tested in trial NCT00622037?
The interventions under investigation include: Systane (DRUG), PEG-400 based artificial tear (DRUG).
Who is sponsoring clinical trial NCT00622037?
This trial is sponsored by Bp Consulting, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.